2m 2m 2m 2m 2m 2m 2m
AVALO THERAP (AVTX)
NASDAQ
$17.63-$0.20 (-1.15%)
Price as of Jun 23, 2026 7:29 PM EDT- $897.8MMarket Cap
- 260.20%1-Year Change
- BiotechnologyIndustry
AVALO THERAP (AVTX)
$17.63-$0.20 (-1.15%)
AVTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $17.83 | ||
Change | +$0.75 (+4.39%) | ||
Open | $16.78 | ||
High | $18.54 | ||
Low | $16.71 | ||
Previous Close | $17.08 | ||
Volume | 1,969,535 | ||
30-Day Average Volume | 1,686,154 | ||
1-Week Change | 24.42% | ||
1-Month Change | 9.05% | ||
1-Year Change | 260.20% | ||
3-Year Change | -98.32% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 52.6M | ||
Total Assets | $99.9M | ||
Market Cap | $897.8M | ||
Enterprise Value | $872.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$19.6M | ||
Free Cash Flow | -$25.2M | ||
EBIT | -$19.6M | ||
EBITDA | -$19.6M | ||
Net Working Capital | $77.2M | ||
EPS | -$0.98 | ||
Enterprise Value/EBITDA | -45 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 13 | ||
P/E | -17 | ||
PEG | 1 | ||
Price/Free Cash Flow | -36 | ||
Price/Operating Cash Flow | -51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 240 | ||
Last Split Date | 12/29/2023 | ||
Earnings & Revenue